4-Azaindole derivatives which are modulators of muscarinic acetylcholine receptor (mAChR) M1 and which may be effective for the prevention or disease modifying or symptomatic treatment of cognitive deficits associated with neurological disorders such as Alzheimer-type dementia (AD) or dementia with Lewy bodies (DLB), and a pharmaceutical composition comprising a 4-azaindole derivative as an active ingredient.
申请公布号
SG11201602052Y(A)
申请公布日期
2016.04.28
申请号
SG11201602052Y
申请日期
2014.09.30
申请人
EISAI R&D MANAGEMENT CO., LTD.
发明人
PAYNE, ANDREW;CASTRO PINEIRO, JOSE LUIS;BIRCH, LOUISE MICHELLE;KHAN, AFZAL;BRAUNTON, ALAN JAMES;KITULAGODA, JAMES EDWARD;SOEJIMA, MOTOHIRO